BioNTech SE (BNTX) FCF Margin Growth (1y) (2020 - 2025)
BioNTech SE (BNTX) FCF Margin Growth (1y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
BioNTech SE |
27.38 Bn |
10.07 Bn |
668.28 Mn |
4,109.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
4,109.00 |
| Sep 30, 2025 |
9,924.00 |
| Jun 30, 2025 |
89,246.00 |
| Mar 31, 2025 |
-34,127.00 |
| Dec 31, 2024 |
-6,321.00 |
| Sep 30, 2024 |
-14,203.00 |
| Jun 30, 2024 |
-132,270.00 |
| Mar 31, 2024 |
-276,354.00 |
| Dec 31, 2023 |
4,062.00 |
| Sep 30, 2023 |
-4,377.00 |
| Jun 30, 2023 |
253,106.00 |
| Mar 31, 2023 |
-11,373.00 |
| Dec 31, 2022 |
1,826.00 |
| Sep 30, 2022 |
11,422.00 |
| Jun 30, 2022 |
12,244.00 |
| Mar 31, 2022 |
6,423.00 |
| Sep 30, 2021 |
-25,908.00 |
| Jun 30, 2021 |
-3,474.00 |
| Mar 31, 2021 |
-22,022.00 |
| Sep 30, 2020 |
11,346.00 |
